Sensibilidad
< 50% |
50 - 85% |
> 85% |
GRAM + |
S Aureus |
MRSA |
S.coag- |
Enteroc |
Neumoc |
Strept. pyogenes |
Strept. Agalactie |
Peni |
4.4 |
0 |
9.3 |
|
85.7 |
100 |
100 |
Oxaci |
100 |
0 |
32 |
|
|
|
|
Ampi |
|
|
|
98.5 |
|
|
|
Cefota |
|
|
|
|
96.8 |
100 |
100 |
Genta |
94.4 |
94.3 |
63.8 |
|
|
|
|
Vanco |
100 |
100 |
100 |
99.7 |
100 |
100 |
100 |
Teico |
100 |
100 |
100 |
|
|
|
|
Rifan |
99.4 |
98.3 |
95.6 |
|
|
|
|
Levo |
|
|
|
|
96'8 |
|
|
Eritro |
88.5 |
50 |
41.4 |
|
79.3 |
80.4 |
85 |
Clinda |
91.1 |
50 |
45 |
|
87.3 |
86.9 |
86 |
Cipro |
92.9 |
4.8 |
48.1 |
|
|
|
|
Cotri |
100 |
96 |
69.5 |
|
|
|
|
Ac.Fus |
|
98.2 |
|
|
|
|
|
Mupiro |
|
93.7 |
|
|
|
|
|
Levo |
|
|
|
|
98'4 |
|
|
GRAM
- |
Coli |
Kleb |
Prot. |
Enterob |
Morga |
pseudo |
Haem |
Campy |
Salm. |
Ampi |
39.7 |
0 |
60.2 |
0 |
0 |
|
90.5 |
|
76.1 |
Amox-Clav |
84.1 |
92 |
95.9 |
0 |
0 |
|
97.6 |
75.2 |
|
Cefuro |
74.8 |
91.1 |
91.8 |
35.2 |
0 |
|
98.8 |
|
|
Cefepime |
95.5 |
96.7 |
98.1 |
85.3 |
96.3 |
|
100 |
|
|
Ceftaz |
|
|
|
|
|
95.4 |
|
|
|
Piper |
|
|
|
|
|
95.9 |
|
|
|
Piper-Taz |
|
|
|
|
|
92.9 |
|
|
|
Imipenem |
|
|
|
|
|
97.2 |
|
|
|
Genta |
92.,1 |
97.3 |
91.9 |
98 |
82.9 |
86.1 |
|
96 |
|
Tobra |
|
|
|
|
|
94.8 |
|
|
|
Cipro |
72.7 |
93.4 |
84.5 |
94.2 |
70.7 |
81.1 |
100 |
12.8 |
100 |
Nitrof |
95.4 |
52.5 |
0 |
43.9 |
0 |
|
|
|
|
Meropen |
|
|
|
|
|
89'8 |
|
|
|
Cotri |
73.1 |
92.6 |
70.1 |
91 |
60.4 |
0 |
|
|
97.4 |
Eritro |
|
|
|
|
|
|
97.6 |
|
|
Levoflox |
|
|
|
|
|
77.9 |
|
|
|
La presencia de cepas de E.Coli y klebsiella
pn. productoras de BLEE continua en aumento, sobretodo en las
muestras de orina de origen comunitario
La incidencia de MRSA sigue estable dentro de una moderada endemicidad. Un 6% de
Mrsa aislados son resistentes a la mupirocina